1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Beneficial effects of alpha-1 antitrypsin therapy in a mouse model of colitis-associated colon cancer
(
- Contribution to journal › Article
- 2016
-
Mark
The protease inhibitor cystatin C downregulates the release of IL-β and TNF-α in lipopolysaccharide activated monocytes
(
- Contribution to journal › Article
- 2009
-
Mark
New Findings in PiZZ alpha(1)-Antitrypsin Deficiency-Related Panniculitis Demonstration of Skin Polymers and High Dosing Requirements of Intravenous Augmentation Therapy
(
- Contribution to journal › Article
- 2008
-
Mark
An association between Type 2 diabetes and alpha(1)-antitrypsin deficiency
(
- Contribution to journal › Article
-
Mark
TNF-alpha-induced self expression in human lung endothelial cells is inhibited by native and oxidized alpha 1-antitrypsin
(
- Contribution to journal › Article
- 2007
-
Mark
alpha1-Antitrypsin regulates CD14 expression and soluble CD14 levels in human monocytes in vitro.
(
- Contribution to journal › Article
-
Mark
Effects of Alzheimer's peptide and alpha 1-antichymotrypsin on astrocyte gene expression
(
- Contribution to journal › Article
- 2006
-
Mark
alpha1-Antitrypsin inhibits Moraxella catarrhalis MID protein-induced tonsillar B cell proliferation and IL-6 release.
(
- Contribution to journal › Article
- 2004
-
Mark
Circulating monocytes and plasma inflammatory biomarkers in active Crohn's disease : Elevated oxidized low-density lipoprotein and the anti-inflammatory effect of artorvastatin
(
- Contribution to journal › Article
- 2003
-
Mark
Pravastatin inhibits pro-inflammatory effects of Alzheimer's peptide Abeta(1-42) in glioma cell culture in vitro.
(
- Contribution to journal › Article